FGDAX | SGGDX | FGDAX / SGGDX | |
Total Expense Ratio | 0.97 | 1.16 | 84% |
Annual Report Gross Expense Ratio | 0.97 | 1.16 | 84% |
Fund Existence | 18 years | 32 years | - |
Gain YTD | 50.169 | 43.360 | 116% |
Front Load | 6% | 5% | 115% |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.24B | 3.56B | 63% |
Annual Yield % from dividends | 2.23 | 3.67 | 61% |
Returns for 1 year | 50.97 | 43.15 | 118% |
Returns for 3 years | 53.97 | 67.10 | 80% |
Returns for 5 years | 41.14 | 65.66 | 63% |
Returns for 10 years | 129.60 | 164.82 | 79% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JACBX | 18.57 | 0.17 | +0.92% |
JHancock Mid Cap Growth I | |||
LIRRX | 9.47 | 0.01 | +0.11% |
Lord Abbett International Value R3 | |||
BILPX | 10.43 | 0.01 | +0.10% |
BlackRock Event Driven Equity Instl | |||
NCIGX | 30.82 | 0.03 | +0.10% |
Nuveen International Value C | |||
PHPSX | 18.24 | -0.02 | -0.11% |
ProFunds Pharmaceuticals UltraSector Svc |